Fairfield Financial Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-500
| Closed | -$5.92K | – | 165 |
|
|
2024
Q4 | $5.92K | Hold |
500
| – | – | ﹤0.01% | 219 |
|
|
2024
Q3 | $5.77K | Hold |
500
| – | – | ﹤0.01% | 245 |
|
|
2024
Q2 | $5.29K | Buy |
+500
| New | +$5.29K | ﹤0.01% | 240 |
|
|
2023
Q4 | $5.62K | Hold |
500
| – | – | ﹤0.01% | 264 |
|
|
2023
Q3 | $5.84K | Hold |
500
| – | – | ﹤0.01% | 252 |
|
|
2023
Q2 | $5.04K | Hold |
500
| – | – | ﹤0.01% | 272 |
|
|
2023
Q1 | $3.66K | Hold |
500
| – | – | ﹤0.01% | 281 |
|
|
2022
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 261 |
|
|
2022
Q3 | $1.61K | Hold |
500
| – | – | ﹤0.01% | 293 |
|
|
2022
Q2 | $2.04K | Hold |
500
| – | – | ﹤0.01% | 273 |
|
|
2022
Q1 | $2.47K | Buy |
+500
| New | +$2.47K | ﹤0.01% | 279 |
|